Association of Race and Ethnicity With High-Potency P2Y12 Inhibitors Prescription Among Patients With Acute MI Undergoing PCI: An Analysis From the CathPCI Registry
Circulation: Cardiovascular Interventions · 2026
DOI: 10.1161/circinterventions.125.015600 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026. Verfasst von Hend Mansoor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Science (H.M.), University of Kentucky, Lexington. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Purinergic P2Y Receptor Antagonists, Healthcare Disparities, Practice Patterns, Physicians'. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Racial and ethnic disparities exist in postacute myocardial infarction (AMI) care. High-potency P2Y12 inhibitors use among patients with AMI who undergo percutaneous coronary intervention (PCI) carries a class I indication in the guidelines. This study aims to examine racial and ethnic differences in high-potency P2Y12 inhibitor prescription on discharge among patients with AMI undergoing PCI. METHODS: Using data from the NCDR Cath PCI registry, we identified consecutive patients with AMI who underwent PCI from April 2018 to June 2023. Likelihood of high-potency P2Y12 inhibitor prescription on discharge was assessed using logistic regression models adjusted for social deprivation index and other patient- and procedure-related variables. RESULTS: Among 1 662 387 patients hospitalized with AMI and who underwent PCI, 165 579 (9.9%) were Black, 58 595 (3.5%) were Asian, and 1 302 576 (78.3%) were of White race, while 135 637 (8.1%) were of Hispanic ethnicity. At discharge 876 078 (52.7%) were prescribed a high-potency P2Y12 inhibitor. Compared with White patients, Black patients were less likely (adjusted odds ratio, 0.93 [95% CI, 0.92–0.94]), while Asians were more likely (adjusted odds ratio, 1.08 [1.07–1.10]) to have a high-potency P2Y12 inhibitor discharge prescription. Compared with non-Hispanics, Hispanic patients were less likely to have a high-potency P2Y12 inhibitor discharge prescription (adjusted odds ratio, 0.95 [95% CI, 0.93–0.96). CONCLUSIONS: In a contemporary national registry of hospitalized patients with AMI who underwent PCI, Black and Hispanic patients were less likely to be discharged on a high-potency P2Y12 inhibitor irrespective of socioeconomic status. These findings highlight an opportunity to achieve equity in guideline-directed AMI pharmacotherapies to improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice and Science (H.M.), University of Kentucky, Lexington.
- Division of Cardiology, Duke University, Durham, NC (R.Y., L.A.K., D.M.W., J.A.R.).
- Duke Clinical Research Institute, Durham, NC (R.Y., L.A.K., D.M.W., J.A.R.).
- Leon H Charney Division of Cardiology, NYU Grossman School of Medicine, New York, NY (B.S.).
- Section of Cardiovascular Medicine, Heart and Vascular Center, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Hanover, NH (I.C.G.).
- Division of Cardiovascular Medicine, Gill Heart and Vascular Institute (I.Y.E.), University of Kentucky, Lexington.
ORCID-Profile: Hend Mansoor, Rebecca Young, Binita Shah, Ian C Gilchrist, Jennifer A Rymer, Islam Y Elgendy
Zitieren
APA
Mansoor, H., Young, R., Kaltenbach, L. A., Wojdyla, D. M., Shah, B., Gilchrist, I. C., Rymer, J. A., & Elgendy, I. Y. (2026). Association of Race and Ethnicity With High-Potency P2Y12 Inhibitors Prescription Among Patients With Acute MI Undergoing PCI: An Analysis From the CathPCI Registry. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.125.015600
Vancouver
Mansoor H, Young R, Kaltenbach LA, Wojdyla DM, Shah B, Gilchrist IC, et al. Association of Race and Ethnicity With High-Potency P2Y12 Inhibitors Prescription Among Patients With Acute MI Undergoing PCI: An Analysis From the CathPCI Registry. Circulation: Cardiovascular Interventions. 2026. doi:10.1161/circinterventions.125.015600
BibTeX
@article{Mansoor2026,
author = {Mansoor, Hend and Young, Rebecca and Kaltenbach, Lisa A and Wojdyla, Daniel M and Shah, Binita and Gilchrist, Ian C and Rymer, Jennifer A and Elgendy, Islam Y},
title = {Association of Race and Ethnicity With High-Potency P2Y12 Inhibitors Prescription Among Patients With Acute MI Undergoing PCI: An Analysis From the CathPCI Registry},
journal = {Circulation: Cardiovascular Interventions},
year = {2026},
doi = {10.1161/circinterventions.125.015600}
}
EUVIMED